Please Note: This trial is no longer enrolling new participants
A Phase 3, Randomized, Open-Label Study Comparing the Efficacy and Safety of the Combination of Beleodaq-CHOP or Folotyn-COP to the CHOP Regimen Alone in Newly Diagnosed Patients with Peripheral T-Cell Lymphoma
| Protocol No. | CTO-SPI-BEL-301 | Scope | National |
|---|---|---|---|
| Principal Investigator | Rita Assi | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase III |
